Experimental investigations on Alport syndrome typically use collagen, type IV, alpha 3–null (Col4a3-null) mice on the 129 or B6 genetic backgrounds and occasionally F1 hybrids thereof. The gene discussed is COL4A3; the disease is Alport syndrome.